NIH Research Matters

Middle-aged woman holds the back of her left hand to her forehead.
News

Antiviral drug did not improve Long COVID symptoms

A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
X-ray of the human lung.
News

tRNA treatment may help restore cystic fibrosis proteins

Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
Medical illustration of Clostridioides difficile bacteria
News

Bacterial infection may alter developing gut

C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.

 

Displaying 442 - 448 of 912

Poverty reduction alters infant brain activity

Cash transfers to low-income mothers led to changes in their infants' brain activity.

Oral immunotherapy for peanut allergy in young children

Giving daily doses of peanut flour to young children with peanut allergies desensitized most and induced remission of the allergy in 21%.

Treatment for opioid use disorder in jail reduces risk of return

Men in a rural jail who received medication to treat opioid use disorder had a reduced likelihood of being arrested or returning to jail or prison after release.

Study suggests COVID-19 vaccines do not reduce fertility

COVID-19 vaccination did not reduce the chances of conception in a study of more than 2,000 couples.

Study suggests Epstein-Barr virus may cause multiple sclerosis

Infection with Epstein-Barr virus, scientists found, dramatically increased the odds of developing multiple sclerosis.

Study reveals brain networks critical for conversation

Researchers identified brain networks involved in planning responses during a conversation.

Gut cells distinguish between sugar and artificial sweeteners

Researchers found cells in the small intestines of mice that communicate with the brain and influence the preference for sugar over artificial sweeteners.